Panitumumab: a new anti-EGFR antibody for the treatment of advanced colorectal cancer
- PMID: 16796785
- DOI: 10.3816/CCC.2006.n.016
Panitumumab: a new anti-EGFR antibody for the treatment of advanced colorectal cancer
Comment on
-
Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer.Clin Colorectal Cancer. 2006 May;6(1):29-31. doi: 10.3816/CCC.2006.n.01. Clin Colorectal Cancer. 2006. PMID: 16796788 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
